 Weve been writing about disruptive technologies like 3D bioprinting for the past seven years now. The promise of bioprinted human tissues is something that wall street analysts have been patiently waiting for for a while now, at least when it comes to Organovo Holdings ONVO. The companys stock has been steadily plummeting over the years while the company tries to commercialized their medical research into bioprinted tissue. In order to understand why Organovo Holdings stock continues to drop, we need to start from the beginning. The Origins of Organovo The story begins in 2010 when Organovo entered into a collaborative 